Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Merkus

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Kidney International|October 22, 2017
A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndromeMariken P Gruppen, Antonia H Bouts, Marijke C Jansen-van der Weide, et al.
JAMA|January 30, 2019
Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical TrialWes Onland, Filip Cools, Andre Kroon, et al.
Trials|September 3, 2015
Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trialSophia M van der Hoeven, Jan M Binnekade, Corianne A J M de Borgie, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 18, 2023
Identifying effect modifiers of systemic hydrocortisone treatment initiated 7-14 days after birth in ventilated very preterm infants on long-term outcome: secondary analysis of a randomised controlled trialNienke Marjolein Halbmeijer, Michel Sonnaert, Renate M Swarte, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 9, 2022
Short-term pulmonary and systemic effects of hydrocortisone initiated 7-14 days after birth in ventilated very preterm infants: a secondary analysis of a randomised controlled trialNienke M Halbmeijer, Wes Onland, Filip Cools, et al.
Trials|February 26, 2026
Presepsin to safely reduce antibiotics in preterm infants (PRESAFE): study protocol for a randomized controlled trial with a concurrent observational studyCharlotte M Nusman, H Rob Taal, Daniel C Vijlbrief, et al.
JAMA|February 28, 2018
Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical TrialDavid M P van Meenen, Sophia M van der Hoeven, Jan M Binnekade, et al.
Trials|May 10, 2018
RELAx - REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trialAnna Geke Algera, Luigi Pisani, Dennis C J Bergmans, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Kidney International|October 22, 2017
A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndromeMariken P Gruppen, Antonia H Bouts, Marijke C Jansen-van der Weide, et al.
JAMA|January 30, 2019
Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical TrialWes Onland, Filip Cools, Andre Kroon, et al.
Trials|September 3, 2015
Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trialSophia M van der Hoeven, Jan M Binnekade, Corianne A J M de Borgie, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 18, 2023
Identifying effect modifiers of systemic hydrocortisone treatment initiated 7-14 days after birth in ventilated very preterm infants on long-term outcome: secondary analysis of a randomised controlled trialNienke Marjolein Halbmeijer, Michel Sonnaert, Renate M Swarte, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 9, 2022
Short-term pulmonary and systemic effects of hydrocortisone initiated 7-14 days after birth in ventilated very preterm infants: a secondary analysis of a randomised controlled trialNienke M Halbmeijer, Wes Onland, Filip Cools, et al.
Trials|February 26, 2026
Presepsin to safely reduce antibiotics in preterm infants (PRESAFE): study protocol for a randomized controlled trial with a concurrent observational studyCharlotte M Nusman, H Rob Taal, Daniel C Vijlbrief, et al.
JAMA|February 28, 2018
Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical TrialDavid M P van Meenen, Sophia M van der Hoeven, Jan M Binnekade, et al.
Trials|May 10, 2018
RELAx - REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trialAnna Geke Algera, Luigi Pisani, Dennis C J Bergmans, et al.
Pageof 7